Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Cyclacel Pharmaceuticals Stock News

CYCCPNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$4.59

0.389.03%

At close: -

$3.40

-1.19-25.93%

After Hours: Apr 7, 8:04 AM EDT

Cyclacel Pharmaceuticals (CYCCP) Forecast

News

Earnings Cyclacel Pharmaceuticals (CYCCP) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Cyclacel Pharmaceuticals Stock News | NASDAQ:CYCCP | Benzinga

Get the latest news on Cyclacel Pharmaceuticals stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Cyclacel Pharmaceuticals performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Thursday, February 27, 2025

Cyclacel Pharmaceuticals Announces Leadership...
Benzinga Newsdesk - Feb 27, 2025, 1:43PM

Thursday, December 05, 2024

Cyclacel Pharmaceuticals Announces Its Explor...
Benzinga Newsdesk - Dec 5, 2024, 4:40PM

Wednesday, November 13, 2024

Cyclacel Pharmaceuticals Announces Exercise O...
Benzinga Newsdesk - Nov 13, 2024, 12:24PM

Tuesday, November 12, 2024

Cyclacel Pharmaceuticals shares are trading h...
Benzinga Newsdesk - Nov 12, 2024, 5:05PM

Wednesday, October 09, 2024

Cyclacel Pharmaceuticals To Present New Clini...
Benzinga Newsdesk - Oct 9, 2024, 9:17AM

Friday, October 04, 2024

12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights - Oct 4, 2024, 12:32PM

Tuesday, June 04, 2024

Cyclacel's Fadraciclib Reports Efficacy In Pa...
Benzinga Newsdesk - Jun 4, 2024, 8:27AM

Monday, June 03, 2024

Cyclacel Pharmaceuticals To Present Clinical ...
Benzinga Newsdesk - Jun 3, 2024, 8:38AM

Friday, April 12, 2024

12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights - Apr 12, 2024, 12:31PM

Monday, April 01, 2024

Cyclacel Pharmaceuticals To Present New Clini...
Benzinga Newsdesk - Apr 1, 2024, 9:16AM

Thursday, March 07, 2024

Cyclacel Pharmaceuticals Announces Preclinica...
Benzinga Newsdesk - Mar 7, 2024, 9:24AM

Wednesday, March 06, 2024

Cyclacel Pharmaceuticals Announces Receipt Of...
Benzinga Newsdesk - Mar 6, 2024, 9:25AM

Thursday, January 11, 2024

12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights - Jan 11, 2024, 12:31PM

Friday, December 22, 2023

Cyclacel Pharmaceuticals Announces $1.3M Regi...
Benzinga Newsdesk - Dec 22, 2023, 9:19AM

Monday, December 18, 2023

Cyclacel Pharmaceuticals Reports Fadraciclib Phase 1 Data Suggesting Efficacy Against Tumors With CDKN2A, CDKN2B And MTAP Deletions
Happy Mohamed - Dec 18, 2023, 9:04AM

Thursday, November 30, 2023

Cyclacel Regains Compliance With Nasdaq Listi...
Benzinga Newsdesk - Nov 30, 2023, 9:19AM

Thursday, November 09, 2023

12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights - Nov 9, 2023, 12:31PM

Thursday, November 02, 2023

12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights - Nov 2, 2023, 1:31PM

Friday, June 02, 2023

12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights - Jun 2, 2023, 1:31PM

Wednesday, May 17, 2023

12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights - May 17, 2023, 1:31PM

Wednesday, May 03, 2023

Cyclacel Pharmaceuticals Announces Receipt of $4.7M R&D Tax Credit
Charles Gross - May 3, 2023, 9:16AM

Thursday, January 05, 2023

Cyclacel Pharmaceuticals Reviews 2022 Achieve...
Benzinga Newsdesk - Jan 5, 2023, 9:16AM

Wednesday, October 26, 2022

Cyclacel Reports Preliminary Data From Phase ...
Benzinga Newsdesk - Oct 26, 2022, 9:16AM

Thursday, October 13, 2022

Cyclacel Pharmaceuticals To Present Prelimina...
Benzinga Newsdesk - Oct 13, 2022, 9:17AM

Wednesday, June 08, 2022

12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights - Jun 8, 2022, 1:53PM

Tuesday, April 19, 2022

Cyclacel Announces Dosing Of First Patient In Phase 1/2 Study Of Oral Cyc140 In Patients With Advanced Solid Tumors And Lymphomas
Bill Haddad - Apr 19, 2022, 9:17AM

Tuesday, April 12, 2022

Cyclacel Pharmaceuticals Announces Publicatio...
Benzinga Newsdesk - Apr 12, 2022, 7:06AM

Wednesday, February 02, 2022

12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights - Feb 2, 2022, 2:22PM

Friday, November 05, 2021

Cyclacel Announces Dosing Of First Patient In...
Benzinga Newsdesk - Nov 5, 2021, 9:44AM

Thursday, November 04, 2021

12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights - Nov 4, 2021, 12:42PM

Friday, October 22, 2021

12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights - Oct 22, 2021, 12:50PM

Monday, August 09, 2021

12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights - Aug 9, 2021, 12:32PM

Tuesday, July 13, 2021

Cyclacel Announces Dosing of First Patient in...
Benzinga Newsdesk - Jul 13, 2021, 7:05AM

Friday, May 28, 2021

12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights - May 28, 2021, 12:32PM

Friday, May 21, 2021

12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights - May 21, 2021, 12:37PM

Wednesday, May 19, 2021

12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights - May 19, 2021, 12:34PM

Monday, March 15, 2021

Cyclacel To Present At Oppenheimer 31st Annua...
Benzinga Newsdesk - Mar 15, 2021, 7:18AM

Friday, March 12, 2021

Cyclacel Pharmaceuticals Prices 1,807,143 Sha...
Benzinga Newsdesk - Mar 12, 2021, 8:33AM

Monday, January 11, 2021

Cyclacel Pharmaceuticals Announces Key Busine...
Benzinga Newsdesk - Jan 11, 2021, 7:53AM

Tuesday, January 05, 2021

12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights - Jan 5, 2021, 12:49PM

Monday, October 26, 2020

Cyclacel Presents Phase 1 Clinical Data Showi...
Benzinga Newsdesk - Oct 26, 2020, 8:28AM

Wednesday, October 07, 2020

11 Healthcare Stocks Moving In Wednesday's Intraday Session
Benzinga Insights - Oct 7, 2020, 2:00PM

Monday, September 21, 2020

Cyclacel Announces Fadraciclib Abstract Selec...
Benzinga Newsdesk - Sep 21, 2020, 7:08AM

Monday, July 13, 2020

Cyclacel's Highlights Publication Of Peer-Rev...
Benzinga Newsdesk - Jul 13, 2020, 7:05AM

Monday, July 22, 2019

Cyclacel Pharmaceuticals Announces First Pati...
Benzinga Newsdesk - Jul 22, 2019, 7:23AM

Monday, April 01, 2019

Cyclacel Pharma Give an Updated From Phase 1 ...
Benzinga Newsdesk - Apr 1, 2019, 7:05AM

Tuesday, October 23, 2018

Stocks Which Set New 52-Week Low Yesterday, O...
Benzinga Newsdesk - Oct 23, 2018, 9:54AM

Monday, September 24, 2018

Stocks Which Set New 52-Week Low Friday, Sept...
Benzinga Newsdesk - Sep 24, 2018, 9:48AM

Monday, April 16, 2018

Cyclacel Reports Presentation of Phase 1 Clinical Data for CDK Inhibitor CYC065 at AACR 2018 Annual Meeting
Benzinga - Apr 16, 2018, 7:06AM

Thursday, September 17, 2015

Cyclacel Announces Presentation of Molecular Rationale for Clinical Development of CYC065 CDK Inhibitor in Leukemias, Lymphomas
Benzinga - Sep 17, 2015, 7:04AM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved